Anti-AGGF1 antibodies are used in the immunodetection of the protein angiogenic factor with G-patch and FHA domains 1. In humans, the canonical protein has a reported length of 714 amino acid residues and a mass of 81 kDa. Its subcellular localization is in the cytoplasm and is secreted. Up to 3 different isoforms have been reported for this protein. It is widely expressed across many tissue types. AGGF1 is reported to promote angiogenesis and the proliferation of endothelial cells. The AGGF1 gene has been associated with the disease, Klippel-Trenaunay syndrome. Synonyms for this target antigen include GPATCH7, HSU84971, HUS84971, VG5Q, G patch domain-containing protein 7, and GPATC7. AGGF1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of AGGF1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.